Stockreport

Bayer's MRI contrast agent gets FDA approval for use in cardiac disease [Reuters]

BAYER AG S/ADR  (BAYRY) 
NASDAQ:AMEX Investor Relations: investor.bayer.com
PDF Bayer's MRI contrast agent gets FDA approval for use in cardiac disease - Reuters 1 Min Read (Reuters) - Bayer AG on Monday said U.S. regulators approved its contrast ag [Read more]